Wockhdart has moved higher by over 9% to Rs 416 after the pharmaceutical firm said that its Swiss arm will list on the Berne Stock Exchange in Switzerland today, 19 December 2013.
The stock opened at Rs 385 and touched a high of Rs 421 on the BSE. A combined 6.29 million shares have changed hands on the counter till late noon deals on the BSE and NSE.
Wockhardt Bio AG, Switzerland has allocated 2.35 million ordinary shares of Swiss Franc (CHF) 1 each representing 5% of the post diluted capital for subscription at a price of CHF 5.05 per ordinary share for its initial public offering, Wockhdart said in a regulatory filing.
The ordinary shares of Wockhardt Bio AG are scheduled to be listed on December 19, 2013 on the Berne Stock Exchange, Switzerland, it added.
Wockhardt Bio AG is the holding company for the pharmaceutical and biotech firm's international operations.
Meanwhile, the stock has recovered 24% in past three trading sessions compared to 0.30% rise in benchmark S&P BSE Sensex. The stock hits 52-week low of Rs 337 on December 16.
The stock opened at Rs 385 and touched a high of Rs 421 on the BSE. A combined 6.29 million shares have changed hands on the counter till late noon deals on the BSE and NSE.
Wockhardt Bio AG, Switzerland has allocated 2.35 million ordinary shares of Swiss Franc (CHF) 1 each representing 5% of the post diluted capital for subscription at a price of CHF 5.05 per ordinary share for its initial public offering, Wockhdart said in a regulatory filing.
The ordinary shares of Wockhardt Bio AG are scheduled to be listed on December 19, 2013 on the Berne Stock Exchange, Switzerland, it added.
Wockhardt Bio AG is the holding company for the pharmaceutical and biotech firm's international operations.
Meanwhile, the stock has recovered 24% in past three trading sessions compared to 0.30% rise in benchmark S&P BSE Sensex. The stock hits 52-week low of Rs 337 on December 16.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%